SWOT Analysis for ATAI Life Sciences N.V. - Opportunity

Add SWOT widget to your site/app

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Significant (over 30%) distance from 52 week high

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

Biggest Price Gainers from Open

Stocks Outperforming their Industry Price Change in the Quarter

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Declining Revenue every quarter for the past 2 quarters

RSI indicating price weakness

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Institutions increasing their shareholding

MFs decreased their shareholding last quarter

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks